EBART 2024 welcomed over 1,500 attendees. The programme of the 5th edition featured 25 presentations and 8 round tables covering the latest advances in reproductive medicine, from treatment personalization to non-invasive embryo selection and emerging challenges in the field.
More than 2,000 attendees from 53 countries and 14 new speakers took part in EBART 2022, in its 4th year
The third edition of the EBART (Evidence-Based Artificial Reproduction Technology) congress took place on 18-19 February 2021 in a new and fresh online format, taking advantage of the convenience and safety provided by technology.
As a prelude to the next edition of the EBART congress, this Campus organized by the Eugin Group aims to continue training through sessions of a didactic nature addressed to embryologists in which they will be able to share and debate with specialists in the field with our focus on clinical evidence.
The second edition of the EBART congress organised by the Eugin Group was attended by more than 400 healthcare professionals from 24 countries. The congress, among other subjects, dealt with the importance of how the Assisted Reproduction Technology professionals have to educate themselves towards an evidence-based approach to medicine without hang-ups and without any kind of fear. Also, about the fact that we have to be more and more aware that education at an early stage of life is the keystone in the fight against fertility.
On April 21st and 22nd, in the city of Barcelona, Eugin Group organised the first such conference in the world to address the scientific evidence of a range of treatments and assisted reproductive techniques that are currently being applied.
